December 4: The Week in Cancer News
Study finds adherence to follow-up screening guidelines is low among people at high risk of developing lung cancer, and more news of the week from Cancer Today.
Study finds adherence to follow-up screening guidelines is low among people at high risk of developing lung cancer, and more news of the week from Cancer Today.
Study suggests that germline genetics may influence lung cancer risk in this patient population. Native American ancestry was associated with increased mutations in the EGFR gene in lung cancer patients from Latin American countries,...
The FDA granted approval to expand the use of a minimally invasive biomarker test to identify certain patients with ovarian, lung, breast, or prostate cancer eligible for treatment with specific molecularly targeted therapeutics.
nce thought sterile, lungs can harbor microbes that may affect lung cancer pathogenesis and prognosis.
Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer.
A trial of the targeted therapy osimertinib for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
The FDA approved the first liquid biopsy companion diagnostic that uses next-generation sequencing to test for EGFR gene mutations in certain types of lung cancer.
Proposed changes to lung cancer screening guidelines would double the number of people eligible for yearly CT scans, and more news of the week from Cancer Today.
The FDA approved an analog of a marine compound to treat certain patients with small cell lung cancer.
Some people with early-stage non-small cell lung cancer can benefit significantly from treatment with a targeted therapy, and more news of the week from Cancer Today.